Counseling Patients on ALS Progression and Prognosis
Key opinion leaders ALS care comment on best practices when communicating with patients about the unpredictability of disease progression and prognosis.
Panelists provide insight into what primary care physicians should consider when differentiating amyotrophic lateral sclerosis (ALS) from conditions with similar presentations.
Efficacy and Safety of Fremanezumab Further Displayed: Stephanie J. Nahas, MD
April 19th 2021The associate professor and director of the Headache Medicine Fellowship Program at Thomas Jefferson University discussed 2 research projects she led presented at AAN 2021 on the efficacy and safety of fremanezumab.
AUPN Leadership Minute Episode 9: Engaging Medical Students in Neurology – Part 2
April 16th 2021Episode 9 of the AUPN Leadership Minute features Donald S. Higgins, Jr., MD, of the Veterans Health Administration; and Douglas J. Gelb, MD, PhD, of the University of Michigan [WATCH TIME: 5 minutes]